Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > “ up to “ …means just that
View:
Post by canadafan on Aug 06, 2024 5:59pm

“ up to “ …means just that

The recent filing? My best read as of now, it says " up to $50 million".
Does not mean it will be a $50million offering. It could be, but not certain.
Just like the shelf perspectus of $200 million. They renew that, I think every 4-5 years.
They did indicate Candor as the agent. And indicate the process woukd be handled as an ATM.
Not sure if existing ATM is still in place withnCanaciord?
Bottom line, they need $ to keep the doors open to finakyze the process.
nothing has changed., they still need to announce the O.S. Results.
as was mentioned in the Q2 update. Strong results will strengthen their negotiation position.
All else the same.
Comment by CMHarring218431 on Aug 09, 2024 9:29am
Hello Canadafan Awhile back, you commented on how, even if Oncy was close to a licensing deal and/or a buyout, they would still have to maintain the posture that it might not happen. Understood. The offering follows with that thinking that they have to be prepared.  Perhaps also, they may have a pretty clear indication that none of the presumed suitors, are gonna dive in anytime soon. Also ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities